2025. Rational Design and In-Silico Evaluation of a Multi-Epitope Vaccine Targeting Human Glypican-3 (GPC3) for Hepatocellular Carcinoma Immunotherapy. Vascular and Endovascular Review. 8, 10s (Nov. 2025), 203–216.